ABIONYX PHARMA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.248 EUR | 0.00% |
|
+0.48% | -3.11% |
| Mar. 14 | Abionyx Pharma: to benefit from a 1ME grant from Bpifrance | CF |
| Mar. 11 | Abionyx: reduced net loss in 2023 | CF |
Chart calendar ABIONYX Pharma
e686ce3eaa545c01c5f680977.-J3-PwNJnAnqrIQ0r8LuPEhjqEDkNzoHLq55e0PcvYM.meS_UDQG7m_b_L19yo2LRXoTwSaNeWxDf9YDEzeJ2Oqv2MtMRSjUX5za8w~5b71551c4dcd1f294c50da641ca01971
Upcoming events on ABIONYX Pharma
Past events on ABIONYX Pharma
| 2024-05-16 12:00 pm | Q1 2024 Sales and Revenue Release |
| 2024-03-11 02:30 am | Q4 2023 Earnings Release |
| 2024-02-28 | Q4 2023 Sales and Revenue Release |
| 2023-11-15 | Q3 2023 Sales and Revenue Release |
| 2023-11-03 10:00 am | American Society of Nephrology Kidney Conference - Poster No: FR-PO1818 |
| 2023-11-02 04:30 pm | American Society of Nephrology Kidney Conference - Poster No: TH-OR080 |
| 2023-11-02 10:00 am | American Society of Nephrology Kidney Conference - Poster No: TH-PO1158 |
| 2023-09-26 02:00 pm | Q2 2023 Earnings Release |
| 2023-08-16 | Q2 2023 Sales and Revenue Release |
| 2023-05-16 | Q1 2023 Sales and Revenue Release |
| 2023-03-29 12:48 pm | Q4 2022 Earnings Release |
| 2023-02-28 12:41 pm | Q4 2022 Sales and Revenue Release |
| 2022-11-16 | Q3 2022 Sales and Revenue Release |
| 2022-09-29 01:39 pm | Interim 2022 Earnings Release |
| 2022-08-17 | Interim 2022 Sales and Revenue Release |
| 2022-05-19 12:00 pm | Q1 2022 Sales and Revenue Release |
| 2022-04-28 12:17 pm | FY 2021 Earnings Release |
| 2022-02-24 12:00 pm | FY 2021 Sales and Revenue Release |
| 2021-11-03 | Q3 2021 Sales and Revenue Release |
| 2021-09-09 12:45 pm | Interim 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,70 0,70 0% | 5,30 2,65 100% | 4,60 4,60 0% | 4,60 |
|
EBITDA Million EUR | Released Forecast Spread | -2,51 -5,87 57.19% | -2,95 -7,30 59.64% | -5,83 -3,00 -94.43% | 0,00 -5,44 - | 0,00 -4,00 - | -5,70 |
|
EBIT Million EUR | Released Forecast Spread | -2,50 -5,87 57.39% | -3,00 -7,30 58.9% | -5,95 -3,25 -83.14% | -4,11 -5,74 28.38% | -3,40 -4,60 26.09% | -6,30 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 1,89 -3,60 152.42% | -1,89 -6,60 71.42% | -5,82 -3,30 -76.42% | 0,00 -6,04 - | 0,00 0,00 - | 0,00 |
|
Net income Million EUR | Released Forecast Spread | 1,80 -0,59 402.77% | -1,90 0,00 - | -5,82 -3,40 -71.24% | -4,21 -5,82 27.76% | -3,50 -4,70 25.53% | -6,50 |
|
EPS EUR | Released Forecast Spread | 0,09 -0,19 147.94% | -0,08 -0,35 77.03% | -0,23 -0,14 -66.52% | 0,00 -0,22 - | 0,00 -0,14 - | -0,16 |
| Announcement Date | 10/03/20 | 25/02/21 | 28/04/22 | 29/03/23 | 11/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 S1 |
|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 2,13 |
|
Net income Million EUR | Released Forecast Spread | -2,25 |
| Announcement Date | 26/09/23 |
More events
Past sector events for ABIONYX Pharma
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ABNX Stock
- Calendar ABIONYX Pharma
